Penumbra, Inc. is a biotechnology-driven medical device company focused on transforming the treatment landscape for neurological and vascular conditions. Based in Alameda, California, Penumbra employs a global reach with operations across major markets, including the United States, Europe, Canada, and Australia. The company's dedication to innovation and quality underpins its portfolio of advanced therapeutic solutions, aimed at improving patient outcomes and enhancing clinician workflows, thereby solidifying its position as a key player within the medical technology sector.